Noblis Autonomous Vehicle Interoperability Concept Receives 2019 Government – Industry Innovator Award


The Noblis Po8 approach can have a significant impact on public sector endeavors, unmanned systems and the future of human-machine interaction.

Noblis, a leading provider of science, technology and strategy services to the federal government has received a 2019 Government – Industry Innovator award from 1105 Public Sector Media Group for Pieces of Eight (Po8), a trusted autonomous operations system that enables ad hoc collections of autonomous machines to communicate, self-organize, and plan coordinated motions and actions based on trust earned in prior interactions. Noblis will be recognized at the Government Innovation Awards event on Nov. 7. The awards celebrate the transformative public-sector activities from government, industry and individuals that are reimagining public-sector IT, according to 1105 Media.

“We are delighted to be recognized as a leader and innovator in the autonomy at scale arena, one of the many research efforts Noblis has undertaken in the past ten years to study the effects of autonomy on a larger scale – across air, sea, land, space and cyber domains,” said Amr ElSawy, Noblis president and chief executive officer. “Innovation is a common thread at Noblis and programs such as Po8 demonstrate how our forward-thinking research and technical solutions are helping our government customers solve their most complex challenges.”

The Noblis Po8 trusted autonomous operations concept has received significant recognition since its public release, including winning the Highest Potential Impact Award and the Most Creative Award at the MOBI (mobility open blockchain initiative) Grand Challenge in Munich, Germany in February 2019. More info here.

MOBI is a nonprofit global foundation formed to accelerate the adoption of standards in blockchain, distributed ledgers, and related technologies for the benefit of consumers, communities and mobility industries.

“The Noblis Po8 approach can have a significant impact on public sector endeavors, unmanned systems and the future of human-machine interaction,” said Mile Corrigan, vice president Federal Civilian Solutions, Noblis. “Our system enables nearby connected machines – such as autonomous passenger vehicles, autonomous drones or autonomous robots traversing hostile terrain – to share situational awareness regarding obstacles and threats projected over time, and collectively plan actions that avoid collision or other conflicts.”

The Noblis Po8 process links heterogenous autonomous machines using ad hoc networking and blockchain technology to demonstrate the effects of orchestrated autonomy in comparison to isolated autonomy. The Po8 system includes an accountability process of trust scores which are recorded on blockchain technology to help ensure transparency, accuracy and the security of the system.

“Po8 allows pick-up teams of autonomous machines to perform as if they have trained together extensively,” said Karl Wunderlich, Noblis research team lead. “Further, if one machine in the system malfunctions or begins to perform erratically, the team will self-organize to re-assign critical team functions and isolate the compromised machine.”

ABOUT NOBLIS

Noblis is a dynamic science, technology, and strategy organization dedicated to creating forward-thinking technical and advisory solutions in the public interest. We bring the best of scientific thought, management, and engineering expertise together in an environment of independence and objectivity to deliver enduring impact on federal missions. Noblis works with a wide range of government clients in the defense, intelligence and federal civil sectors. Together with our wholly owned subsidiary, Noblis ESI, we tackle the nation’s toughest problems and support our clients’ most critical missions.

Share article on social media or email:



Source link

LifeCare Announces New Mobile App For Its Industry Leading Backup Care Service


LifeCare

LifeCare

As demand for our backup care services continue to escalate, we thought it important to offer our members even greater flexibility to manage it all through this best-in-class app.

The country’s leading work-life provider, LifeCare, is pleased to announce the launch of its new Backup Care Connection mobile app, supporting their premier backup care assistance service known for helping employees minimize disruption when their regular care arrangements fall through. With the app’s release, LifeCare is making it more convenient for members to manage all aspects of their backup care needs, whenever and wherever they are.

“As demand for our backup care services continue to escalate, we thought it important to offer our members even greater flexibility to manage it all through this best-in-class app,” says Peter Burki, CEO of LifeCare, “Now members can engage with us through any method they prefer — phone, web or app — to receive the right backup care solution they need.”

The app allows members to manage all aspects of their Backup Care benefit, including the ability to request care for their covered dependents such as children, seniors, pets and even themselves. Additional features include ability for employees to track their backup care utilization, view available visits, update or modify upcoming care reservations, submit for reimbursement and more.

According to Apperian, 91% of corporate employees are using at least one mobile app. Employees expect that the services they need be available as an app on their mobile devices, available at their fingertips. With the new Backup Care Connection mobile app, reliable backup care is just a few taps away.

Employers that offer Backup Care Connection to their employees recognize the value of the service, both in helping to alleviate the caregiving burden faced by their workforce and helping to reduce employee absenteeism. With the robust and flexible solution offered by LifeCare, children, aging loved ones, pets and even employees who are recovering from serious illness or surgery are covered.

As Burki referenced, LifeCare’s backup care services have seen steady growth in both demand and usage as more and more corporations look to provide valuable, productivity-enhancing care support for their employees. These nationwide companies specifically choose LifeCare’s Backup Care Connection because it’s the most flexible in the industry, enabling members to choose from a large selection of network care providers, locations, and out-of-network options (including their own preferred privately secured caregiver such as a personal babysitter, friend or even family member). Plus, members can schedule care up to 30 days in advance or even at the last minute. As a result, Backup Care Connection offers unmatched efficiency in reducing employee stress while increasing their work attendance and productivity.

Beyond Backup Care Connection — as the country’s leading work-life provider — LifeCare assists its members in the areas of parenting, senior care, legal guidance, financial help, home services and wellness. Specifically, LifeCare’s specialists provide personalized guidance 24/7/365 and connect employees with the solutions they need, when and where they need them.

About LifeCare

LifeCare provides employer-sponsored work-life benefits to 61,000 clients, including Fortune 500 companies and large branches of the federal government, representing 100 million members nationwide. In addition to child and backup care solutions, LifeCare also provides a full suite of work-life solutions that save members time with personal life needs such as Senior Care Management, Homework Connection, Mothers@Work, MilkShip, LeaveCoach and BenConnect. LifeCare also operates LifeMart, an online discount shopping website that provides real savings on everyday products and needs. LifeCare is headquartered in Shelton, CT.

Share article on social media or email:



Source link

Study shows Mesenchymal Stromal Cells importance of tissue origin in predicting function


A new study released today in STEM CELLS demonstrates that mesenchymal stromal cells (MSCs) expanded from adipose tissue (ASC) outperform those expanded from bone marrow (BM-MSCs). Importantly, while several previous studies have compared the performance of BM-MSCs versus ASCs, this is the first to pair MSCs from the same donor to show that tissue, rather than donor origin, is the functional predictor.

“Numerous clinical trials are evaluating the therapeutic potential of MSCs in degenerative and inflammatory diseases,” said lead investigator Karin Tarte, Pharm D, Ph.D., of the Université de Rennes. “However, the influence of their tissue of origin on their functional properties, including their immunosuppressive activity, remains unsolved.

“Prior to our study, the comparison of ASCs versus BM-MSCs was essentially completed using MSC batches obtained from different donors. We demonstrated for the first time on a large series of ASCs and BM-MSCs, obtained from the same donors, the strong impact of tissue origin on these cells’ properties. Moreover,” she added, “we pinpointed that ASCs could be an interesting alternative to BM-MSCs for therapeutic applications, considering their huge expression of anti-inflammatory and immunosuppressive molecules.”

To conduct their study, the investigators produced paired BM-MSC and ASC batches from 14 healthy donors, cultured under identical clinical grade-like conditions. They then compared them using transcriptomic (that is, all RNA molecules in a cell or a population of cells), phenotype (their physical characteristics) and functional analyses. Lastly, they validated the results on purified native MSCs to infer which differences were really endowed by tissue of origin.

What they learned was that the cultured MSCs segregated together by tissue origin rather than donor origin, which translated into distinct immune-related gene signatures, phenotypes and functional cell interactions.

“In particular, ASCs exhibited an immune profile consistent with a stronger inhibition of T-cell and myeloid cell immune response and a lower immunogenicity,” Dr. Tarte said. “This study supports the need to select therapeutic MSCs by tissue of origin functionality,” she concluded.

“The ability to assess key characteristics of adipose and bone marrow-derived mesenchymal stem/stromal cells from the same individual has not before been done on such a defined and large-scale manner,” said Dr. Jan Nolta, Editor-in-Chief of STEM CELLS. “The report from Tarte et al gives us an important comparison from which we can draw key insight for future clinical trials”.

The full article, “Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells,” can be accessed at https://stemcellsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/stem.3077.

About the Journal: STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research. STEM CELLS is co-published by AlphaMed Press and Wiley.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes three internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. STEM CELLS® (http://www.StemCells.com) is the world’s first journal devoted to this fast paced field of research. THE ONCOLOGIST® (http://www.TheOncologist.com) is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. STEM CELLS TRANSLATIONAL MEDICINE® (http://www.StemCellsTM.com) is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company’s website can be accessed at http://www.wiley.com.

Share article on social media or email:



Source link

LensDirect.com Named to 2019 Inc. 5000 List for Third Year in a Row


https://www.prweb.com/

LensDirect.com – One of The Most Successful Companies in America

“We’re excited to once again be honored by Inc. Magazine as one of America’s fastest-growing private companies,” – Ryan Alovis, CEO of LensDirect.com

Inc. Magazine has announced that LensDirect.com, one of North America’s largest independent retailer of optical goods has been ranked in 1101th place on the annual Inc. 5000, the most prestigious ranking of the nation’s fastest growing private companies.

The list represents the most successful companies within the American economy’s most dynamic segment – independent small businesses.

Many well-known companies first gained national exposure as honorees on the Inc. 5000. Companies like Microsoft, Dell, Domino’s Pizza, LinkedIn, Zillow, Yelp, Pandora, and many others.

“We’re excited to once again be honored by Inc. Magazine as one of America’s fastest-growing private companies,” said Ryan Alovis, CEO of LensDirect.com. “With over 70% of North American adults having corrective vision needs, yet the eyecare industry is plagued by inconvenience, high costs, and subpar customer care – LensDirect.com is uniquely positioned to become America’s Optical Store.”

LensDirect.com expects its growth numbers to continue to rise as it puts more emphasis on enriching their customer relationships. Over the past few years, they’ve launched novel concepts such as their ‘set it and forget it’ AutoRefill Subscription and Dedicated Account Reps. Those endeavors have been key factors in its extraordinary customer satisfaction rating of 97%.

Additionally, LensDirect.com is dedicated to becoming a single-source full-service online optical store by expanding their product offerings with accessories, premium sunglasses, prescription eyewear and lens replacement.

“The companies on this year’s Inc. 5000 have followed so many different paths to success,” says Inc. editor in chief James Ledbetter. “There’s no single course you can follow or investment you can take that will guarantee this kind of spectacular growth. But what they have in common is persistence and seizing opportunities.”

Complete results of the Inc. 5000 can be found at http://www.inc.com/inc5000.

For more information on LensDirect.com, please visit the company’s website at http://www.lensdirect.com

About LensDirect.com

Founded in 1992, LensDirect.com is a New York-based online retailer of optical goods. Originally a contact lens mail order company, it has evolved into the leading provider of name-brand contact lenses, accessories, sunglasses, prescription eyewear and lens replacement on the internet.. With a customer first mentality, LensDirect.com has found its place as one of the highest-rated online retailers.

About Inc. 5000

The Inc. 5000 is a list of the fastest-growing private companies in the nation. Started in 1982, this prestigious list has become the hallmark of entrepreneurial success. The Inc. 5000 Conference & Awards Ceremony is an annual event that celebrates the remarkable achievements of these companies. The event also offers informative workshops, celebrated keynote speakers, and evening functions.

Share article on social media or email:



Source link

Purdue Pharma Deal Leaves Opioid-Dependent Babies Out in the Cold


A legal team continues to work with the Judge Polster towards establishing a designated settlement class for NAS children, said Ms. Brustowicz. “Negotiations are ongoing”, she added.

On August 27, 2019 it was reported for the first time that Purdue and its lawyers met, on August 20, 2019, in Cleveland, Ohio before the MDL Judge, the Plaintiffs and the Attorney Generals representing some 10 States to offer upwards of $12 billion to settle to the nearly 2,000 lawsuits filed by municipalities and Native American tribes and these States.

What sounds like a positive step forward, following so close behind Oklahoma’s landmark verdict against Johnson & Johnson for its role in America’s current drug crisis is, in actuality, a bombshell to the team of attorneys, non-profit advocates and medical experts fighting for the more than 200,000 children born with Neonatal Abstinence Syndrome (NAS) because their mothers used prescription opioids while pregnant.

“We are deeply involved in complex litigation to create a medical monitoring trust fund for babies diagnosed with NAS,” said Celeste Brustowicz of the Opioid Justice Team. “Both these legal actions leave to chance any hope for these innocent victims because they take the easy way out and offer a blanket settlement in favor of government general funds.”

There are more than 35 state class actions on behalf of NAS children filed and awaiting a specific recognition in the opioid multi-district litigation currently before federal Judge Dan Polster. Those representing these children have for years explained why a settlement track replicating the infamous Big Tobacco settlement would not help these children.

Many legal experts have also weighed in, warning that many of the government entities which reached a record $206 billion settlement with the leading cigarette makers are using the settlement monies for general fund needs, ignoring pleas by health experts that substantial dollars must be spent on smoking cessation programs, especially those aimed at children.

Medical experts are in agreement that NAS babies will suffer from some combination of social, interactive, behavioral, cognitive and educational deficits, from the time of birth onwards; nonetheless, substantial intervention improves the quality of life and outcomes for child and caregiver alike, said health representative Brent Bell. The most immediate crisis arises from the fact that the most severe NAS symptoms occur while these babies are in Neo-Natal Intensive Care Units, including uncontrollable trembling and seizures, gastrointestinal complications, and sleep abnormalities.

“The Purdue Pharma settlement plan is an outrage because it fails in any way to address that crisis,” said Mr. Bell. “In fact, the medical maxim ‘dose makes the poison’ is a theory of awarding damages utilized by Purdue’s proposal which is why it is facile and appears egregiously and hopelessly flawed. Under Purdue’s current proposal these child victims of the opioid crisis get nothing.”

As reported, the plan calls for Purdue Pharma to declare Chapter 11 bankruptcy and emerge restructured as a for-profit public benefit trust. Purdue claims the value of the trust would include the provision of more than $4-billion in drugs to cities, counties and states (the ‘in-kind’ payment component), together with the profits to be derived from the sale of drugs, totaling an additional $7-8 billion (the ‘direct payment’ component).

“The fund is scheduled to expire after 10 years, allowing Purdue and the Sackler family, alike, to go on as if nothing had ever happened,” said Ms. Brustowicz.

“It sounds like a financial coup for governments that have borne substantial costs from the opioid epidemic, but it’s only a good deal if you forget about these NAS babies who wouldn’t get a dime under this plan,” said Greg Williams, the former director of Facing Addiction and an addiction recovery advocate.

A legal team continues to work with the Judge Polster towards establishing a designated settlement class for NAS children, said Ms. Brustowicz. “Negotiations are ongoing”, she added.

“Although we are confident that our babies will ultimately prevail and receive justice, they haven’t yet gained status as a negotiated settlement class, which is why the news of the separate deal for Purdue Pharma is so unsettling,” says Ms. Brustowicz.

Opioid Justice Team is a group of highly skilled attorneys who have engaged with doctors and civic leaders fighting to end our nation’s opioid epidemic by identifying real solutions to the crisis. What sets our team apart is our commitment to our clients not only to obtain compensation for their damages, but to advocate for a comprehensive settlement that will address the root causes of the opioid crisis and eliminate the systemic conditions that allow it to exist. We’re about justice, relief, and answers to the short and long-term challenges of America’s unprecedented prescription opioid addiction problem.

Share article on social media or email:



Source link

Innovative Pathogenic DNA Analysis Technology to be Explored on Advancements Television Series.


News Image

“Our software translates pathogenic DNA data from ATCG to symptoms, such as fever or pneumonia, so that doctors and patients can easily understand the health impacts of the pathogens.”

An upcoming episode of Advancements with Ted Danson scheduled to broadcast 1Q/2020 will educate about the latest developments in genome sequencing analysis. Check your local listings for more information.

Advancements will go behind-the-scenes to learn about the innovation taking place at Rivermap Research & Consulting and will explore its revolutionary pathogenic DNA analysis technology, which predicts in real-time, the possible health impacts from microorganisms, proteins or any manmade DNA strains.

“Our software translates pathogenic DNA data from ATCG to symptoms, such as fever or pneumonia, so that doctors and patients can easily understand the health impacts of the pathogens. The scientists who design DNA food/drugs can also use this software to confirm the functions and side-effects of their products at the design stage. Viewers will see how this little soldier is making great contributions in the healthcare industry,” said Mai Wang, CEO of Rivermap Research and Consulting.

Analyses results are generated in REAL TIME. The technology will also enable healthcare providers to use alternative medicine, such as local herbs, for treatment. Watch Advancements to learn more.

About Rivermap Research & Consulting:

Rivermap translates pathogenic DNA data to symptoms which allows doctors and patients to directly understand the health impacts of pathogens. It also enables using alternative medicine to treat infectious diseases at lower cost. The same technology can be used by scientists as a safety test tool for their synthetic DNA products at design stage, reducing a large portion of the R&D cost. For more information, visit: http://www.rivermapsolution.com.

About Advancements and DMG Productions:

The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit http://www.AdvancementsTV.com or call Richard Lubin at 866-496-4065.

Share article on social media or email:



Source link

New Discovery Can Ease Opioid Crisis


WhiteHill Life Science LLC announces that its most recent National Stage filing of its patent WO 218/236539 A 1 can unlock methods to combat the opioid crisis.

“The opioid crisis is not hopeless, nor must it be without end. Recent court decisions and settlements surrounding prescription opioids underscore the need for solutions that can be implemented now, not years from now, and are easy to administer and at low cost,” from Ron Butler, CEO.

Our scientific team lead by Dr. Dale Brown PhD engaged in research for several years that culminated in a patent filed with a priority date of June 20, 2017 and an international filing through WIPO (World Intellectual Property Organization) May 28, 2018. That pending patent titled Synergistic Compositions and Methods of Achieving Homeostasis in Mammalian Systems was moved to National Stage filing in the US recently. It has been published and can be accessed as WO 218/236539 A1.

Dr. Brown explains, “We know that pain, inflammatory diseases and conditions, even addictions, can be interdicted via the ionotropic cannabinoid channels by certain artificial and natural compositions. We have demonstrated in our recently published pending patent filing, that a simple device like a lozenge slowly dissolving in the mouth can deliver non-prescription pain relief without any addictive properties found in various cannabis products. The FDA scrutiny of CBD and cannabis-based products is timely and much needed to protect users. There are implications for Alzheimer’s based on observations of enhanced cannabinoid receptors of the Alzheimer’s brain. We focus on alternatives that are simple and straightforward based on sound science,” said Dr. Brown.

“Not all corporate decisions have to be about optimizing profits for shareholders. There are stakeholders in every community that can benefit from this discovery,” said Mr. Butler.

Those interested in discussing our Intellectual Property can contact senior management at WhiteHill: inquiries(at)WHLifeSciences(dot)com

Share article on social media or email:



Source link

Shriners for Children Medical Center Physicians Named Top Doctors by Pasadena Magazine


Photo Credit: Nate Taylor

Physician’s at Shriners for Children Medical Center

“It takes a whole team of people to make these miracles happen every day, and we are proud to see several physicians receiving accolades from their peers,” said Christopher Dougherty, administrator at Shriners for Children Medical Center.

Four Shriners for Children Medical Center physicians have been named Top Doctors by Pasadena Magazine. These physicians have been recognized among the best doctors in the San Gabriel Valley for providing high-quality, compassionate care in their respective pediatric subspecialties:

  • Robert H. Cho, M.D. – Chief of Staff, scoliosis, spinal deformity surgery, limb deformity, pediatric orthopaedic trauma
  • William Magee, M.D., D.D.S. – Chief of Plastics, director of cleft lip and palate program, facial reconstruction, microtia, burn reconstruction
  • Katherine Au, M.D. – Congenital and post-traumatic hand reconstruction, burn reconstruction, breast reconstruction, microsurgery
  • Frederic R. Bushnell, M.D. – Anesthesiology


“It takes a whole team of people to make these miracles happen every day, and we are proud to see several physicians receiving accolades from their peers,” said Christopher Dougherty, administrator at Shriners for Children Medical Center.

“The commitment to personalized patient care and family experience is part of our culture and shared by all of our staff,” added Robert H. Cho, M.D. “Our innovative approach to pediatric pain management allows us to treat many conditions with minimal to no opiate use and has become the model that many pediatric centers follow. Our state-of-the-art clinic, physical therapy, and operating rooms allow us to care for children in a world-class environment. We welcome all children with neuromuscular conditions, scoliosis and spine problems, sports injuries, fractures, congenital hand disorders, cleft lip and palate, burns, and urologic disorders.”

Pasadena Magazine surveyed doctors from across the San Gabriel Valley and Los Angeles to identify the most esteemed physicians in their respective fields. Results of the annual peer-to-peer survey are published in the September 2019 print edition and online.

Shriners Hospitals for Children is changing lives every day through innovative pediatric specialty care, world-class research, and outstanding medical education. Shriners for Children Medical Center – Pasadena is a regional pediatric medical center providing care to children with orthopedic conditions, plastics reconstructive surgery, rehabilitation, and orthotics and prosthetic services regardless of the families’ ability to pay. To schedule an appointment, call (626) 389-9300 or visit us online at shcla.org.

Share article on social media or email:



Source link

South Dakota School of Mines & Technology Invites Business Investment in New Generation Battery Technology During Conference


https://www.prweb.com/

Dr. Alevtina Smirnova

“Solid-state is the future of energy storage,” says Dr. Alevtina Smirnova, an associate professor of chemistry and applied biological sciences and electrical and computer engineering at SD Mines.

Research scientists at South Dakota School of Mines & Technology will host hundreds of industry representatives, the National Science Foundation (NSF) and fellow academics on Thursday and Friday, Sept. 12-13, in a bid to establish an international center to develop solid-state batteries which will be safer, cheaper, smaller and more efficient than lithium ion batteries.

The center would be a huge economic boost to both SD Mines as well as the state of South Dakota, says Dr. Alevtina Smirnova, an associate professor of chemistry and applied biological sciences and electrical and computer engineering at Mines.

Smirnova and research scientist Dr. Abu Md “Numan” Numan-Al-Mobin are leading the grant proposal to NSF for the establishment of the Center for Green Solid-State Electric Power Generation and Storage(CEPS). Smirnova and Numan are responsible for the coordination of the Sept. 12-13 conference.

“We are excited about the possibility of Mines taking such a major role in new green technology that could really change the world,” Smirnova says. “We hope CEPS will become the center for development of eco-friendly, safe and economically feasible all-solid-state energy storage technology.”

Smirnova says the solid batteries developed in CEPS would be ideal for portable and medical applications, the automotive industry, centralized and decentralized electric grids, military applications and energy security.

Some of the industry leaders attending the conference include Ford (attending remotely), Swiss company LafargeHolcim, Garmin International, Caterpillar Inc., Naval Air Systems Command, Solvay of Belgium, Collins Aerospace, L3Harris Technologies, 3M and Parker-Hannifin Corporation.

The push to find safer, more sustainable batteries is the “holy grail” right now, Smirnova says.

“The reality is, conventional lithium-ion batteries are not safe or reliable.” Conventional batteries contain a liquid, that renders them flammable, dangerous and costly. In 2016, the lithium ion batteries in Samsung’s Galaxy Note 7 computers cost the company $10 billion when many of the batteries exploded.

This week’s conference is the second step in the process to bring CEPS to its fully-funded fruition. Smirnova was awarded a $60,000 NSF planning grant in January to create an Industry/University Cooperative Research Center (IUCRC) on campus. With SD Mines as the lead center, three other universities became “sites” to work on specific pieces of the research needed to make solid-state batteries a reality. Those universities are South Dakota State University in Brookings, University of South Dakota in Vermillion and Northeastern University in Massachusetts. Each university received $15,000 of the planning grant.

Under the NSF grant process, Mines and the three sites must now secure three business partnerships with companies, with each company contributing $50,000. NSF will match the $50,000 for the first three partners up to $600,000 per year. NSF also requires Mines and each site to partner with national labs for research assistance.

The NSF program strives to create cooperative research centers that create long-term partnerships among industry, academia and government.

The $50,000 investment by industry will give them a seat at the CEPS Industry Advisory Board, a vote in the CEPS research and development portfolio, the ability to monitor progress in the development of the technology, involvement in the development and approval of CEPS’ bylaws and the retainment of non-exclusive licenses to develop products. They will also be helping to train students for future employment, supporting the economic development of South Dakota and supporting sustainable electric power grids, Smirnova says.

NSF will evaluate CEPS’ progress during the conference this week. If the requirements are in place and CEPS can show it can attract members from industry, Smirnova will be asked to submit a full grant in December, requesting $600,000 per year for 5 years in grant funding for the project. The funds must be matched 1:1 by industry.

If NSF approves CEPS for full funding, the center and its three sites will have 10 to 15 years to become self-sustaining.

“We welcome these companies to our campus and look forward to sharing this exciting research with them,” Smirnova says. “Solid-state is the future of energy storage.”

Share article on social media or email:



Source link

Medigap Premiums Grew More Than Twice the Rate of the Social Security COLA Over Past Year — Forecast Worse for Next Year According to The Senior Citizens League


https://www.prweb.com/

Mary Johnson

“Inflation is lower this year, and we are estimating that the COLA is likely to be around 1.7 percent,” Johnson says. “Nevertheless, we anticipate that Medigap premiums will continue to grow several times faster for a number of reasons,” Johnson adds.

According to a new survey by The Senior Citizens League (TSCL), premiums for Medicare supplemental insurance, known as Medigap, grew more than twice as fast as Social Security cost – of – living -adjustments (COLA) in the past year. About 41 percent of survey participants who are covered by a Medigap policy report robust premium increases in the past 12 months of at least 6 percent or more, particularly for individuals who were covered by a policy for more than two years. “The Social Security COLA for 2019 is 2.8 percent, far lower than the rate that Medigap policies appear to be growing,” says Mary Johnson, a Social Security and Medicare policy analyst for The Senior Citizens League.

In addition to rapidly growing Medigap premiums, retirees also must pay for premiums for Medicare Part B and their drug plans. The combination takes a bigger bite out of Social Security benefits and other retirement resources when COLAs fail to keep pace. “The financial drain on benefits is difficult to anticipate, and many retirees don’t have adequate savings to begin with,” Johnson says.    

The disparity between growth in the COLA and Medigap premiums is likely to be worse in 2020. “Inflation is lower this year, and we are estimating that the COLA is likely to be around 1.7 percent,” Johnson says. “Nevertheless, we anticipate that Medigap premiums will continue to grow several times faster for a number of reasons,” Johnson adds.

Two of the most popular Medigap plans, “F” and “C,” will no longer be offered for sale in 2020. “While individuals enrolled in these plans may keep their plans, we are concerned that premiums for these plans could rise significantly without younger and healthier new enrollees to spread the costs in those plans,” Johnson says.

In 2019, there are a total of ten different Medigap plans, “A” through “N.” Congress closed Plans “F” and “C” because they cover the Medicare Part B deductible. The thinking is that deductibles prevent “over utilization” of Medicare benefits. The Part B deductible is $135.50 this year and it rises at the same pace as the Part B premium. According to research by Johnson, Part B premiums have increased about 10 percent per year since 2000, making it one of the fastest growing costs in retirement. “Requiring retirees to pay deductibles, or higher deductibles, has the biggest financial and health impact on middle-income Medicare beneficiaries with modest means,” says Johnson. “Many put off medically necessary care if they can’t afford the deductible, and their health can get worse when they do,” she says.

About one quarter of all Medicare beneficiaries are covered by Medigap polices. Out-of-pocket costs under Medicare are considerable, and most beneficiaries supplement their coverage either by purchasing a Medigap policy or joining a Medicare Advantage plan. Unlike Medicare Advantage, however, Medigap enrollees in most states are not able to switch to another Medigap policy during fall open enrollment, because insurers are not required to cover pre-existing conditions outside of the individual’s initial enrollment period. Seventy-two percent of survey participants support extending guaranteed coverage for pre-existing conditions to Medigap, allowing Medigap enrollees greater freedom to switch to other, less costly, Medigap plans.

The Senior Citizens League supports legislation that protects Medicare benefits and lowers out-of-pocket costs for beneficiaries. To learn how to get involved, visit http://www.SeniorsLeague.org.

With 1.2 million supporters, The Senior Citizens League is one of the nation’s largest nonpartisan seniors’ groups. Its mission is to promote and assist members and supporters, to educate and alert senior citizens about their rights and freedoms as U.S. Citizens, and to protect and defend the benefits senior citizens have earned and paid for. The Senior Citizens League is a proud affiliate of The Retired Enlisted Association. Visit http://www.SeniorsLeague.org for more information.

Share article on social media or email:



Source link

Press Release News Wire Service